Recent Blog Posts
-
A Big Fat Geek Survey
May 25 20123:56 pm EDT -
Phasing Out Instagram
May 25 20122:27 pm EDT -
UberConference Is Victorious!
May 24 20121:49 pm EDT -
Ark Floats, Olive Branch Unseen
May 21 20126:30 pm EDT -
Teach the Internet to Forget
May 21 20124:39 pm EDT -
Microsoft Patent Begs the Question:
Who Needs Developers?
May 17 20123:30 pm EDT -
Mozilla's Monitor-Me-Not
May 17 201211:38 am EDT -
Google's Brain Gets Humanized
May 16 20125:30 pm EDT -
Pandora Demographics Aim Wedding Proposal
May 16 201212:19 pm EDT -
New York Techies Get Mappy Way to Job Hunt
May 15 20122:50 pm EDT
Links
- Engadget
- Pandora
- GigaOM
- USA TODAY Tech
- Somewhat Frank's tech conference list
- BuzzTracker Tech
- The Long Tail
- Tom Foremski
- Roger McGuinn's Folk Den
- John Battelle's SearchBlog
- Mark Cuban's blog
- SciTech Daily
- Romenesko
- Kevin Maney's site
- Steven Johnson
- Marc Andreessen
- TechCrunch
- Fred Wilson
- paidContent
- Spiedies, mmmm
- TechFlash
Questcor: From Orphan Drug To Orphan Stock?
Blaise Zerega can't fathom an 1,800% price hike. Russ Mitchell's examination yesterday of why Questcor Pharmaceuticals raised the price of a drug used to treat infantile epilepsy from $1,600 per vial to $23,000 per vial helps set the stage for Congressional hearings tomorrow. But in the meanwhile, the company's share price is already taking a hit, down 9% to $4.57 as of this posting. What if it QCOR shares eventually fell 1,800%? Instant karma, anyone?
. □
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
